Cargando…

Second primary malignancies among cancer patients

BACKGROUND: Rate of second primary malignancies (SPM) is steadily increasing over the last decades. New therapies, early diagnostic markers, screening tests for a larger number of individuals contribute to the increase prevalence of SPM. In the current study, we try to described the demographic comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xuanqi, Li, Xiao, Wang, Minqi, Shen, Jianfei, Sisti, Giovanni, He, Zelai, Huang, Jinfeng, Li, Yan Michael, Wu, Aimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290649/
https://www.ncbi.nlm.nih.gov/pubmed/32566575
http://dx.doi.org/10.21037/atm-20-2059
_version_ 1783545727076532224
author Zheng, Xuanqi
Li, Xiao
Wang, Minqi
Shen, Jianfei
Sisti, Giovanni
He, Zelai
Huang, Jinfeng
Li, Yan Michael
Wu, Aimin
author_facet Zheng, Xuanqi
Li, Xiao
Wang, Minqi
Shen, Jianfei
Sisti, Giovanni
He, Zelai
Huang, Jinfeng
Li, Yan Michael
Wu, Aimin
author_sort Zheng, Xuanqi
collection PubMed
description BACKGROUND: Rate of second primary malignancies (SPM) is steadily increasing over the last decades. New therapies, early diagnostic markers, screening tests for a larger number of individuals contribute to the increase prevalence of SPM. In the current study, we try to described the demographic composition of SPM victims, distribution of primary sites, and the impact of related factors on prognosis. METHODS: We conducted a retrospective study identifying patients over the age of 18 who were diagnosed with SPM from the 16 most common cancer sites between 2000 and 2013 from Surveillance, Epidemiology, and End Results data. Cox proportional hazards regression was used to analyze the relationship between different factors associated to the prognosis of SPM. Standard incidence rate of multiple primary (MP-SIR) was also calculated. RESULTS: A total of 303,753 patients were diagnosis with SPM and 76,168 of whom (25.08%) were included in our analytic cohort. Patients with prostate cancer was vulnerable to SPM, accounting for 34.59%, and SPM was prone to occur in lung and bronchus, accounting for 24.90%. The heat map shows that esophagus cancer survivors have the highest risk of developing stomachache tumors (SIR =5.08). The result of Cox regression suggests that a history of liver was associated with the shortest survival time (HR =1.64, 95% CI, 1.54–1.75, P<0.001). CONCLUSIONS: With the advancement of medical standards, the survival time of cancer patients is prolonged, but the occurrence of SPM is also increasing, and the prognosis is not optimistic. More attention needs to be invested in the prevention and treatment of SPM.
format Online
Article
Text
id pubmed-7290649
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-72906492020-06-19 Second primary malignancies among cancer patients Zheng, Xuanqi Li, Xiao Wang, Minqi Shen, Jianfei Sisti, Giovanni He, Zelai Huang, Jinfeng Li, Yan Michael Wu, Aimin Ann Transl Med Original Article BACKGROUND: Rate of second primary malignancies (SPM) is steadily increasing over the last decades. New therapies, early diagnostic markers, screening tests for a larger number of individuals contribute to the increase prevalence of SPM. In the current study, we try to described the demographic composition of SPM victims, distribution of primary sites, and the impact of related factors on prognosis. METHODS: We conducted a retrospective study identifying patients over the age of 18 who were diagnosed with SPM from the 16 most common cancer sites between 2000 and 2013 from Surveillance, Epidemiology, and End Results data. Cox proportional hazards regression was used to analyze the relationship between different factors associated to the prognosis of SPM. Standard incidence rate of multiple primary (MP-SIR) was also calculated. RESULTS: A total of 303,753 patients were diagnosis with SPM and 76,168 of whom (25.08%) were included in our analytic cohort. Patients with prostate cancer was vulnerable to SPM, accounting for 34.59%, and SPM was prone to occur in lung and bronchus, accounting for 24.90%. The heat map shows that esophagus cancer survivors have the highest risk of developing stomachache tumors (SIR =5.08). The result of Cox regression suggests that a history of liver was associated with the shortest survival time (HR =1.64, 95% CI, 1.54–1.75, P<0.001). CONCLUSIONS: With the advancement of medical standards, the survival time of cancer patients is prolonged, but the occurrence of SPM is also increasing, and the prognosis is not optimistic. More attention needs to be invested in the prevention and treatment of SPM. AME Publishing Company 2020-05 /pmc/articles/PMC7290649/ /pubmed/32566575 http://dx.doi.org/10.21037/atm-20-2059 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zheng, Xuanqi
Li, Xiao
Wang, Minqi
Shen, Jianfei
Sisti, Giovanni
He, Zelai
Huang, Jinfeng
Li, Yan Michael
Wu, Aimin
Second primary malignancies among cancer patients
title Second primary malignancies among cancer patients
title_full Second primary malignancies among cancer patients
title_fullStr Second primary malignancies among cancer patients
title_full_unstemmed Second primary malignancies among cancer patients
title_short Second primary malignancies among cancer patients
title_sort second primary malignancies among cancer patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290649/
https://www.ncbi.nlm.nih.gov/pubmed/32566575
http://dx.doi.org/10.21037/atm-20-2059
work_keys_str_mv AT zhengxuanqi secondprimarymalignanciesamongcancerpatients
AT lixiao secondprimarymalignanciesamongcancerpatients
AT wangminqi secondprimarymalignanciesamongcancerpatients
AT shenjianfei secondprimarymalignanciesamongcancerpatients
AT sistigiovanni secondprimarymalignanciesamongcancerpatients
AT hezelai secondprimarymalignanciesamongcancerpatients
AT huangjinfeng secondprimarymalignanciesamongcancerpatients
AT liyanmichael secondprimarymalignanciesamongcancerpatients
AT wuaimin secondprimarymalignanciesamongcancerpatients
AT secondprimarymalignanciesamongcancerpatients